Home > Boards > US Listed > Biotechs > Applied DNA Sciences Inc. (APDN)

Thank_You_ROCKET, keeping_our_little_light_shining:). AppreciateYa! Got_some_PR__level_news on_a_Lin

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
mcsharkey Member Profile
 
Followed By 21
Posts 6,832
Boards Moderated 1
Alias Born 05/14/11
160x600 placeholder
Applied DNA Schedules Fiscal 2019 Fourth Quarter Financial Results Conference Call for Thursday, December 12, 2019 at 4:30 PM... Business Wire - 12/5/2019 5:00:00 AM
 Applied DNA Sciences Subsidiary LineaRx Signs Agreement with TYME Technologies for Functional Invasive Circulating Tumor Ce... Business Wire - 11/26/2019 12:30:00 PM
Applied DNA Sciences Regains Compliance with Nasdaq Listing Standards Business Wire - 11/25/2019 1:17:00 PM
Applied DNA Sciences Reports 14 Development Customers for its Linear DNA Manufacturing Platform Business Wire - 11/25/2019 9:15:00 AM
Applied DNA Sciences Announces Closing of Upsized $12.0 Million Underwritten Public Offering Business Wire - 11/15/2019 12:08:00 PM
Applied DNA Sciences Announces Pricing of Upsized $12.0 Million Underwritten Public Offering Business Wire - 11/13/2019 9:20:00 AM
Registration of Additional Securities (up to 20%) (s-1mef) Edgar (US Regulatory) - 11/13/2019 9:13:26 AM
Successful DNA Tagging of Leather at One of the World’s Largest Tanneries Business Wire - 11/12/2019 9:03:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/8/2019 4:17:47 PM
Applied DNA Sciences Announces Appointment of Scott L. Anchin to Board of Directors  Business Wire - 11/8/2019 3:22:00 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/8/2019 3:15:19 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/1/2019 5:22:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/31/2019 4:07:01 PM
Applied DNA Sciences Announces 1-For-40 Reverse Stock Split Business Wire - 10/31/2019 1:00:00 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 10/25/2019 4:28:35 PM
Applied DNA Receives Notice of Allowance on Patent Protecting its CertainT® Platform in Cellulosic Fibers and Materials Business Wire - 10/22/2019 8:30:00 AM
Applied DNA Partners with Molecular Isotope Technologies to Elevate CertainT® for Brand Assurance and Provenance Business Wire - 10/16/2019 5:30:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/8/2019 4:02:30 PM
Molecular Tagging of Pharmaceutical Excipients Utilizing Applied DNA’s Technology Published in Peer-Reviewed Journal Business Wire - 10/4/2019 5:00:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 10/3/2019 4:03:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/3/2019 6:32:21 AM
Applied DNA Receives Extension from Nasdaq Business Wire - 10/3/2019 5:00:00 AM
LineaRx’s iCTC Platform for Isolation of Circulating Tumor Cells Shows Superior Correlation over PSA as a Biomarker in Pros... Business Wire - 10/1/2019 8:30:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 9/26/2019 5:23:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/25/2019 4:03:37 PM
mcsharkey   Saturday, 10/19/19 03:28:27 PM
Re: RodeKroet post# 56629
Post # of 57024 
Thank_You_ROCKET, keeping_our_little_light_shining:). AppreciateYa! Got_some_PR__level_news on_a_LineaRX_collaboration we_got_going_on TYME Presents Business Update and Announces Second Quarter Fiscal 2020 Conference Call and Preliminary Operational Results

We got our first alert on our "collaboration" with TYME just back on the 1st of October @THIS LINK. I like this very promising NYC cancer research group we're collaborated with through LineaRX, as much as I used to like Theracann. And, they're still on the table. Too many issues, and just blowing smoke to discuss pot. Need to pull for our business on LineaRX because:
Quote:
They already are listed (TYME) on the NASDAQ.

They have real cash. As of September 30, 2019, the end of its second fiscal quarter, the Company had approximately $15.3 million in cash and cash equivalents compared to $19.5 million as of June 30, 2019. TYME’s operational cash burn rate for the second quarter of fiscal year 2020 was $4.2 million compared to $4.7 million for the second quarter of fiscal year 2019.

And on Thursday, reported results of this recently completed Phase II trial using SM-88 to treat recurrent prostate cancer at the Congress of the European Society of Medical Oncology (ESMO), one of the preeminent meetings for highlighting new cancer therapies and diagnostics.

All I got for a bit.

Hoping everyone is voting. And voting YES on Proposal 2.
Quote:
PROPOSAL 2
APPROVAL OF THE ADJOURNMENT OF THE SPECIAL MEETING TO SOLICIT ADDITIONAL PROXIES


In the event that the number of shares of our common stock present in person or represented by proxy at the Special Meeting and voting “FOR” the adoption of the Reverse Stock Split is insufficient to adopt the Reverse Stock Split, we may move to adjourn the Special Meeting in order to enable the Board to solicit additional proxies in favor of the adoption of the Reverse Stock Split. In that event, we will ask stockholders to vote only upon this Proposal 2 and not on Proposal 1. If the adjournment is for more than thirty (30) days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.

If a quorum is present, Proposal 2, approval of the proposal to adjourn the Special Meeting to a later date, requires the affirmative vote of the majority of the votes cast on the proposal. Abstentions and broker non-votes will not be considered votes cast on Proposal 2 and will therefore not have any effect with respect to Proposal 2.

The Board Recommends a Vote FOR the Adjournment of the Special Meeting to Solicit Additional Proxies if there Are Insufficient Proxies at the Special Meeting to Approve the Reverse Stock Split. Proxies that Are Returned Will Be so Voted Unless Otherwise Instructed.


GLTUA


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist